276 related articles for article (PubMed ID: 37894850)
1. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis.
Brandenburg K; Ferrer-Espada R; Martinez-de-Tejada G; Nehls C; Fukuoka S; Mauss K; Weindl G; Garidel P
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894850
[TBL] [Abstract][Full Text] [Related]
2. Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides.
Martinez de Tejada G; Heinbockel L; Ferrer-Espada R; Heine H; Alexander C; Bárcena-Varela S; Goldmann T; Correa W; Wiesmüller KH; Gisch N; Sánchez-Gómez S; Fukuoka S; Schürholz T; Gutsmann T; Brandenburg K
Sci Rep; 2015 Sep; 5():14292. PubMed ID: 26390973
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.
Aboudounya MM; Heads RJ
Mediators Inflamm; 2021; 2021():8874339. PubMed ID: 33505220
[TBL] [Abstract][Full Text] [Related]
4. The role of serum circulating microbial toxins in severity and cytokine storm of COVID positive patients.
Fallah A; Sedighian H; Behzadi E; Havaei SA; Kachuei R; Imani Fooladi AA
Microb Pathog; 2023 Jan; 174():105888. PubMed ID: 36402345
[TBL] [Abstract][Full Text] [Related]
5. Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions.
Root-Bernstein R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672738
[TBL] [Abstract][Full Text] [Related]
6. Targeting bacterial endotoxin: two sides of a coin.
Bosshart H; Heinzelmann M
Ann N Y Acad Sci; 2007 Jan; 1096():1-17. PubMed ID: 17405910
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 suppresses TLR4-induced immunity by dendritic cells via C-type lectin receptor DC-SIGN.
van der Donk LEH; Bermejo-Jambrina M; van Hamme JL; Volkers MMW; van Nuenen AC; Kootstra NA; Geijtenbeek TBH
PLoS Pathog; 2023 Oct; 19(10):e1011735. PubMed ID: 37844099
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 4 decoy, TOY, attenuates gram-negative bacterial sepsis.
Jung K; Lee JE; Kim HZ; Kim HM; Park BS; Hwang SI; Lee JO; Kim SC; Koh GY
PLoS One; 2009 Oct; 4(10):e7403. PubMed ID: 19816595
[TBL] [Abstract][Full Text] [Related]
9. Increased TLR4 Expression Aggravates Sepsis by Promoting IFN-
Li Q; Wu C; Liu Z; Zhang H; Du Y; Liu Y; Song K; Shi Q; Li R
J Immunol Res; 2019; 2019():3737890. PubMed ID: 30915370
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Fasciola hepatica Fatty Acid Binding Protein as a Novel Anti-Inflammatory Biotherapeutic Drug in an Acute Gram-Negative Nonhuman Primate Sepsis Model.
Rosado-Franco JJ; Armina-Rodriguez A; Marzan-Rivera N; Burgos AG; Spiliopoulos N; Dorta-Estremera SM; Mendez LB; Espino AM
Microbiol Spectr; 2021 Dec; 9(3):e0191021. PubMed ID: 34937173
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide production by endotoxin preparations in TLR4-deficient mice.
Cauwels A; Bultinck J; De Zwaef R; Vandendriessche B; Magez S; Brouckaert P
Nitric Oxide; 2014 Jan; 36():36-43. PubMed ID: 24269486
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.
Sohn KM; Lee SG; Kim HJ; Cheon S; Jeong H; Lee J; Kim IS; Silwal P; Kim YJ; Paik S; Chung C; Park C; Kim YS; Jo EK
J Korean Med Sci; 2020 Sep; 35(38):e343. PubMed ID: 32989935
[TBL] [Abstract][Full Text] [Related]
13. Nitrite Attenuates the In Vitro Inflammatory Response of Immune Cells to the SARS-CoV-2 S Protein without Interfering in the Antioxidant Enzyme Activation.
Ferrer MD; Reynés C; Jiménez L; Malagraba G; Monserrat-Mesquida M; Bouzas C; Sureda A; Tur JA; Pons A
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474248
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Sepsis.
Koçak Tufan Z; Kayaaslan B; Mer M
Turk J Med Sci; 2021 Dec; 51(SI-1):3301-3311. PubMed ID: 34590796
[TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
16. Orally administered BZL-sRNA-20 oligonucleotide targeting TLR4 effectively ameliorates acute lung injury in mice.
Zhao D; Qin Y; Liu J; Tang K; Lu S; Liu Z; Lin Y; Zhang C; Huang F; Chang J; Li C; Tian M; Ma Y; Li X; Zhou C; Li X; Peng X; Jin N; Jiang C
Sci China Life Sci; 2023 Jul; 66(7):1589-1599. PubMed ID: 36808291
[TBL] [Abstract][Full Text] [Related]
17. Antibiotic induced endotoxin release and clinical sepsis: a review.
Holzheimer RG
J Chemother; 2001 Nov; 13 Spec No 1(1):159-72. PubMed ID: 11936361
[TBL] [Abstract][Full Text] [Related]
18. An update on endotoxin neutralization strategies in Gram-negative bacterial infections.
Brandenburg K; Schromm AB; Weindl G; Heinbockel L; Correa W; Mauss K; Martinez de Tejada G; Garidel P
Expert Rev Anti Infect Ther; 2021 Apr; 19(4):495-517. PubMed ID: 33210958
[TBL] [Abstract][Full Text] [Related]
19. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
[TBL] [Abstract][Full Text] [Related]
20. Effects of local lipopolysaccharide administration on the expression of Toll-like receptor 4 and pro-inflammatory cytokines in uterus and oviduct of rabbit does.
Menchetti L; Barbato O; Filipescu IE; Traina G; Leonardi L; Polisca A; Troisi A; Guelfi G; Piro F; Brecchia G
Theriogenology; 2018 Feb; 107():162-174. PubMed ID: 29161657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
